Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$31.86 - $67.26 $350 - $739
-11 Reduced 0.01%
112,059 $4.86 Million
Q1 2023

Apr 26, 2023

SELL
$45.44 - $74.26 $8.62 Million - $14.1 Million
-189,783 Reduced 62.87%
112,070 $7.36 Million
Q4 2022

Feb 09, 2023

SELL
$41.39 - $81.0 $4.77 Million - $9.33 Million
-115,160 Reduced 27.62%
301,853 $13.6 Million
Q3 2022

Nov 01, 2022

BUY
$72.36 - $113.1 $3.93 Million - $6.15 Million
54,368 Added 14.99%
417,013 $30.2 Million
Q2 2022

Aug 02, 2022

BUY
$87.2 - $114.05 $6.83 Million - $8.94 Million
78,343 Added 27.56%
362,645 $38.9 Million
Q1 2022

May 11, 2022

SELL
$94.19 - $124.49 $27.4 Million - $36.2 Million
-290,680 Reduced 50.55%
284,302 $31.5 Million
Q4 2021

Feb 08, 2022

BUY
$119.57 - $139.07 $9.44 Million - $11 Million
78,987 Added 15.92%
574,982 $73.6 Million
Q3 2021

Nov 09, 2021

BUY
$109.17 - $142.35 $12.9 Million - $16.9 Million
118,563 Added 31.41%
495,995 $66 Million
Q2 2021

Aug 12, 2021

SELL
$100.34 - $115.69 $5.96 Million - $6.87 Million
-59,409 Reduced 13.6%
377,432 $40.8 Million
Q1 2021

May 11, 2021

SELL
$101.51 - $125.27 $34.2 Million - $42.2 Million
-336,566 Reduced 43.52%
436,841 $46 Million
Q4 2020

Feb 05, 2021

SELL
$85.88 - $105.36 $2.72 Million - $3.33 Million
-31,627 Reduced 3.93%
773,407 $80.5 Million
Q3 2020

Nov 04, 2020

SELL
$72.74 - $92.5 $9.62 Million - $12.2 Million
-132,202 Reduced 14.11%
805,034 $69 Million
Q2 2020

Aug 06, 2020

SELL
$48.02 - $79.04 $5.17 Million - $8.51 Million
-107,649 Reduced 10.3%
937,236 $68.7 Million
Q1 2020

May 06, 2020

BUY
$36.95 - $62.95 $6.7 Million - $11.4 Million
181,378 Added 21.0%
1,044,885 $54.3 Million
Q4 2019

Feb 07, 2020

BUY
$47.06 - $56.64 $1.86 Million - $2.23 Million
39,435 Added 4.79%
863,507 $48.6 Million
Q3 2019

Nov 08, 2019

SELL
$47.45 - $58.05 $8.74 Million - $10.7 Million
-184,119 Reduced 18.26%
824,072 $39.3 Million
Q2 2019

Aug 06, 2019

SELL
$39.26 - $54.21 $5.34 Million - $7.37 Million
-135,907 Reduced 11.88%
1,008,191 $0
Q1 2019

May 10, 2019

SELL
$29.84 - $43.92 $13,965 - $20,554
-468 Reduced 0.04%
1,144,098 $46.4 Million
Q4 2018

Feb 06, 2019

BUY
$29.95 - $46.34 $25 Million - $38.7 Million
834,939 Added 269.66%
1,144,566 $35.7 Million
Q3 2018

Nov 08, 2018

BUY
$40.12 - $45.55 $12.4 Million - $14.1 Million
309,627 New
309,627 $14.1 Million
Q2 2018

Aug 02, 2018

SELL
$38.72 - $42.52 $616,770 - $677,301
-15,929 Closed
0 $0
Q1 2018

Apr 20, 2018

SELL
$39.4 - $47.39 $2,521 - $3,032
-64 Reduced 0.4%
15,929 $654,000
Q4 2017

Jan 25, 2018

BUY
$37.27 - $43.02 $313,328 - $361,669
8,407 Added 110.82%
15,993 $657,000
Q3 2017

Nov 03, 2017

BUY
$33.75 - $41.67 $256,027 - $316,108
7,586
7,586 $303,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.